Skip to content

Liquidia Corporation LQDA Change in Other Liabilities

Change in Other Liabilities at other companies

Tenet Healthcare logo
Tenet HealthcareTHC
$0+100%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$21M+6,207%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$4.62M+56.8%
TG Therapeutics logo
TG TherapeuticsTGTX
-$1.62M+12.8%
Alkermes logo
AlkermesALKS
$4.89M+71.5%
Roivant Sciences logo
Roivant SciencesROIV
-$252K-230%

Other financials

Income statement

See full
Revenue$132.9M+4,158%
Gross profit$1.6M+6.5%
Operating income$61.5M+274%
Net income$52.9M+238%
EPS (diluted)$0.52+216%

Balance sheet

See full
Cash & equivalents$222.8M+31.2%
Total debt$7.0M+1.5%
Total equity$108.6M+118%
Total assets$401.5M+76.6%

Cash flow

See full
Operating cash flow$53.0M+273%
CapEx$2.8M+758%
Free cash flow$50.2M+262%

Valuation

See full
Market cap$6.32B+164%
Enterprise value$6.1B+184%
P/S21.9×-147×

Profitability

See full
Gross margin58.1%-18.7pp
Operating margin-155%-68.1pp
Net margin-176.2%-76.4pp
FCF margin-150.7%-64.4pp

Returns & leverage

See full
Return on equity-181%+57.4pp
Debt / equity0.1×-0.1×
Current ratio2.2×-0.7×

Where this comes from

Reported directly by Liquidia Corporation in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities.

The official record: Liquidia Corporation’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Liquidia Corporation's change in other liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Liquidia Corporation's change in other liabilities?
Liquidia Corporation (LQDA) reported change in other liabilities of $873K in Q1 2026.
What does change in other liabilities mean?
Change in miscellaneous liabilities affecting operating cash flow.